Jubilant Pharmova P/E Ratio

Current P/E Ratio

40.97

High Valuation

Very High - High growth expectations or significantly overvalued

Jubilant Pharmova (JUBLPHARMA) P/E ratio is 40.97 (High), EPS (TTM) ₹25.15, current price ₹965.35 on NSE vs historical average P/E of 19.63 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. See Jubilant Pharmova P/B valuation to compare market price against book value per share.

Current Valuation Metrics

P/E Ratio 40.97

Current Price ₹965.35

EPS (TTM) ₹25.15

Exchange NSE

Valuation Signal

Signal Overvalued

Historical Avg 19.63

Historical Range 9.61 - 39.54

Percentile 100.0%

Sector Context

Sector Average 55.72

Sector Median 31.4

Sector Rank #11 of 194

Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹31.34

Mar 2026 ₹7.55

Sept 2025 ₹7.59

JUBLPHARMA P/E Ratio — Valuation Signal & Historical Context

Jubilant Pharmova P/E 40.97 vs historical average 19.63, range 9.61–39.54 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see JUBLPHARMA share price screener.

Stock appears overvalued with PE of 40.97, suggesting caution for new investments
Current PE is 108.7% above historical average
Trading at discount to sector average PE of 55.72

Jubilant Pharmova P/E Ratio Historical Trend

JUBLPHARMA annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 40.97 vs historical average 19.63. Read Jubilant Pharmova dividend payments for the complete payout history and dividend yield track record.

JUBLPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation

Jubilant Pharmova annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year	P/E Ratio	EPS (₹)	Year-end Price (₹)	Exchange	Valuation
2025	39.54	27.31	₹1079.90	NSE	High
2021	23.87	35.69	₹851.80	NSE	Moderate
2020	9.61	55.4	₹532.65	NSE	Low
2018	14.62	53.18	₹777.60	NSE	Low
2017	15.19	40.94	₹621.95	NSE	Moderate
2016	14.93	28.06	₹419.05	NSE	Low

JUBLPHARMA vs Healthcare Peers — P/E Ratio Comparison

Jubilant Pharmova P/E 40.97 vs Healthcare average 55.72, median 31.4 — range 2.86–916.67.

Sector Average

55.72

Sector Median

31.4

Lowest P/E

2.86

Highest P/E

916.67

Companies

194

Company	Symbol	P/E Ratio	Market Cap (₹ Cr)	Valuation
Murae Organisor	MURAE	2.86	₹41	Low
Phaarmasia	PHRMASI	3.61	₹64	Low
Sunrest Lifescience	SUNREST	3.76	₹30	Low
Sun Pharma Advanced Rese…	SPARC	4.76	₹7,399	Low
Shelter Pharma	SHELTER	5.23	₹47	Low
Dipna Pharmachem	DPL	5.39	₹14	Low
JFL Life Sciences	JFLLIFE	5.41	₹68	Low
Amwill Health Care	AMWILL	7.26	₹83	Low
Zenith Drugs	ZENITHDRUG	7.69	₹84	Low
Galaxy Medicare	GML	7.8	₹27	Low